BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 30913953)

  • 1. Endometriosis-associated ovarian cancer is a single entity with distinct clinicopathological characteristics.
    Li Q; Sun Y; Zhang X; Wang L; Wu W; Wu M; Meng C; Liu G
    Cancer Biol Ther; 2019; 20(7):1029-1034. PubMed ID: 30913953
    [No Abstract]   [Full Text] [Related]  

  • 2. Endometriosis-associated Ovarian Cancer: A Distinct Clinical Entity?
    Bounous VE; Ferrero A; Fuso L; Ravarino N; Ceccaroni M; Menato G; Biglia N
    Anticancer Res; 2016 Jul; 36(7):3445-9. PubMed ID: 27354606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometriosis-associated ovarian carcinoma (EAOC): an entity distinct from other ovarian carcinomas as suggested by a nested case-control study.
    Erzen M; Rakar S; Klancnik B; Syrjänen K
    Gynecol Oncol; 2001 Oct; 83(1):100-8. PubMed ID: 11585420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometriosis-associated ovarian cancer is not a distinct clinical entity among young patients: A 12-year cohort study.
    Cai Y; Yin J; Jin Y; Li Y; Wu M; Yang J; Huang H; Leng J; Pan L
    Eur J Surg Oncol; 2020 May; 46(5):876-882. PubMed ID: 31837932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometriosis-associated Ovarian Cancer is a Subset With a More Favorable Outcome and Distinct Clinical-pathologic Characteristics.
    Bassiouny D; El-Baz MA; Gamil TM; Shams N; Ismiil N; Dubé V; Han G; Cesari M; Lu FI; Slodkowska E; Chiu HF; Naeim M; Li N; Nofech-Mozes S; Khalifa MA
    Int J Gynecol Pathol; 2019 Sep; 38(5):435-442. PubMed ID: 30059454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unraveling the two entities of endometrioid ovarian cancer: a single center clinical experience.
    Mangili G; Bergamini A; Taccagni G; Gentile C; Panina P; Viganò P; Candiani M
    Gynecol Oncol; 2012 Sep; 126(3):403-7. PubMed ID: 22609111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of concurrent endometriosis on the prognosis of women with ovarian clear cell or endometrioid carcinoma.
    Ju UC; Kang WD; Kim SM
    Int J Gynaecol Obstet; 2019 Aug; 146(2):177-183. PubMed ID: 31081117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of endometriosis in patients with stage I ovarian clear cell carcinoma: Experiences at three academic institutions.
    Bai H; Cao D; Yuan F; Sha G; Yang J; Chen J; Wang Y; Zhang Z; Shen K
    Gynecol Oncol; 2016 Dec; 143(3):526-531. PubMed ID: 27745918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes of patients with clear cell and endometrioid ovarian cancer arising from endometriosis.
    Paik ES; Kim TJ; Choi CH; Kim BG; Bae DS; Lee JW
    J Gynecol Oncol; 2018 Mar; 29(2):e18. PubMed ID: 29400011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk and prognosis of ovarian cancer in women with endometriosis: a meta-analysis.
    Kim HS; Kim TH; Chung HH; Song YS
    Br J Cancer; 2014 Apr; 110(7):1878-90. PubMed ID: 24518590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk factors of endometriosis associated ovarian carcinoma in women aged 45 years and older].
    He ZX; Wang S; Li ZF; Zhu L; Leng JH; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2017 May; 52(5):314-319. PubMed ID: 28545269
    [No Abstract]   [Full Text] [Related]  

  • 12. Predictive factors of ovarian carcinoma for women with ovarian endometrioma aged 45 years and older in China.
    He ZX; Shi HH; Fan QB; Zhu L; Leng JH; Sun DW; Li ZF; Shen K; Wang S; Lang JH
    J Ovarian Res; 2017 Jul; 10(1):45. PubMed ID: 28716151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation between endometriosis-associated ovarian cancers and non- endometriosis-associated ovarian cancers based on magnetic resonance imaging.
    Zhang X; Li M; Tang Z; Li X; Song T
    Br J Radiol; 2021 Sep; 94(1125):20201441. PubMed ID: 33882252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression and significance of GLI1 and Shh in the malignant transformation of ovarian endometriosis].
    Zhao F; Yu XP; Zhao H; Song BB; Lyu AW; Zhang SH; Wang LM
    Zhonghua Fu Chan Ke Za Zhi; 2022 Feb; 57(2):125-132. PubMed ID: 35184473
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence for the Relationship Between Endometriosis and Epithelial Ovarian Cancer.
    del Carmen MG
    Obstet Gynecol Surv; 2015 Sep; 70(9):587-95. PubMed ID: 26403563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADP-ribosylation factor-like 4C predicts worse prognosis in endometriosis-associated ovarian cancers.
    Wakinoue S; Chano T; Amano T; Isono T; Kimura F; Kushima R; Murakami T
    Cancer Biomark; 2019; 24(2):223-229. PubMed ID: 30594917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the presence of endometriosis associated with a survival benefit in pure ovarian clear cell carcinoma?
    Sahin H; Sari ME; Cuylan ZF; Haberal AN; Sirvan L; Coban G; Yalcin I; Güngör T; Celik H; Meydanli MM; Ayhan A
    Arch Gynecol Obstet; 2018 Apr; 297(4):1005-1013. PubMed ID: 29383437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histologic Subtypes in Endometriosis-Associated Ovarian Cancer and Ovarian Cancer Arising in Endometriosis: A Systematic Review and Meta-Analysis.
    Chiaffarino F; Cipriani S; Ricci E; Esposito G; Parazzini F; Vercellini P
    Reprod Sci; 2024 Jun; 31(6):1642-1650. PubMed ID: 38438776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abundance of mitochondrial superoxide dismutase is a negative predictive biomarker for endometriosis-associated ovarian cancers.
    Amano T; Chano T; Isono T; Kimura F; Kushima R; Murakami T
    World J Surg Oncol; 2019 Jan; 17(1):24. PubMed ID: 30700285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between endometriosis and survival outcomes of ovarian cancer: Evidence-based on a meta-analysis.
    Yang B; Wang D; Chen H; Yang F
    Niger J Clin Pract; 2015; 18(5):577-83. PubMed ID: 26096232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.